National Peroxide Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Revenue	2,897	2,869	3,330
Revenue Growth (YoY)	0.99%	-13.85%	-
Cost of Revenue	1,850	2,075	2,227
Gross Profit	1,047	793.78	1,103
Selling, General & Admin	264.77	304.41	292.75
Other Operating Expenses	470.78	337.27	434.45
Operating Expenses	943.45	842.76	919.8
Operating Income	103.96	-48.98	183.32
Interest Expense	-13.55	-16.65	-19.82
Interest & Investment Income	-	6.64	5.14
Currency Exchange Gain (Loss)	-	4.05	6.03
Other Non Operating Income (Expenses)	59.72	9.92	12.9
EBT Excluding Unusual Items	150.13	-45.03	187.57
Gain (Loss) on Sale of Investments	-	24.26	25.43
Gain (Loss) on Sale of Assets	-	-	2.13
Other Unusual Items	-5.82	-	-
Pretax Income	144.32	-20.77	215.14
Income Tax Expense	33.95	1.7	47.24
Net Income	110.37	-22.46	167.9
Net Income to Common	110.37	-22.46	167.9
Shares Outstanding (Basic)	6	6	6
Shares Outstanding (Diluted)	6	6	6
Shares Change (YoY)	0.03%	-	-
EPS (Basic)	19.20	-3.91	29.22
EPS (Diluted)	19.20	-3.91	29.22
Free Cash Flow	297.91	137.78	217.7
Free Cash Flow Per Share	51.83	23.97	37.88
Dividend Per Share	7.000	-	12.500
Gross Margin	36.15%	27.67%	33.13%
Operating Margin	3.59%	-1.71%	5.50%
Profit Margin	3.81%	-0.78%	5.04%
Free Cash Flow Margin	10.28%	4.80%	6.54%
EBITDA	311.86	145.24	367.33
EBITDA Margin	10.76%	5.06%	11.03%
D&A For EBITDA	207.9	194.22	184.01
EBIT	103.96	-48.98	183.32
EBIT Margin	3.59%	-1.71%	5.50%
Effective Tax Rate	23.52%	-	21.96%
Revenue as Reported	2,957	2,914	3,381

Source: S&P Global Market Intelligence. Standard template. Financial Sources.